Relapse of primary CNS lymphoma after more than 10 years in complete remission [5]

Journal of Neurology

Volumn 252, Issue 11, 2005, Pages 1409-1410

  Herrlinger, Ulrich ^a,b   Hebart, Holger ^b   Kanz, Lothar ^b   Dichgans, Johannes ^a   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; B CELL LYMPHOMA; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; HUMAN; LARGE CELL LYMPHOMA; LETTER; MALE; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, DIFFUSE; MALE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PROCARBAZINE; VINCRISTINE;

EID: 28144445051     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0854-4     Document Type: Letter

References (12)

1. Glass JP, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphomas: long-term outcome. J Neurosurg 81:188-195
2. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859-863
3. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20:4643-4648
4. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489-4495
5. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment of primary CNS lymphoma: the next step. J Clin Oncol 18:3144-3150
6. Pöttgen C, Stuschke M, Stuben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T (2003) Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Strahlenther Onkol 179:626-632
7. Herrlinger U, Brugger W, Bamberg M, Küker W, Dichgans J, Weller M (2000) PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 54:1707-1708
8. Lee AY, Connors JM, Klimo P, O'Reilly SE, Gascoyne RD (1997) Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. J Clin Oncol 15:1745-1753
9. Mead GM, Mackintosh FR, Burke JS, Rosenberg SA (1983) Late relapse from complete remission in nodular and diffuse histiocytic lymphoma. Cancer 52:1356-1359
10. Ko AH, Yuen AR (2002) Clinical outcomes associated with very late relapses in diffuse large cell lymphoma. Leuk Lymph 43:1789-1793
11. Dejong D, Glas AM, Boerrigter L, Hermus MC, Dalesio O, Willemse E, Nedelof PM, Kersten MJ (2003) Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features. Blood 102:324-327
12. Isikdogan A, Ayyildiz O, Buyukcelik A, Soker M, Buyukbayram H (2003) Late relapse of non-Hodgkin's lymphoma after a 28-year disease-free interval: an unusual case. Ann Hematol 82:712-713